EGFR and non-small cell lung carcinoma: To identify novel mechanisms contributing to EGFR-TKI acquired resistance in NSCLC, we performed proteome profiler array analysis in gefitinib-sensitive parent cell lines (PC9 and HCC827) and gefitinib-resistant cell lines (PC9GR and HCC827GR).